Development of the selective micropulse individual retinal therapy depends on age and type on the Fitzpatrick scale

/ Publications / Development of the selective micropulse individual retinal therapy depends on age and type on the Fitzpatrick scale

Development of the selective micropulse individual retinal therapy depends on age and type on the Fitzpatrick scale

Authors: Ivanova EV, Volodin PL.
Presented: January 1, 2022
Type: Publications

The developed selective micropulse individual retinal therapy (SMIRT) is effective for CSCR treatment with a probability damage detection (PDD) of 90%.

Related publications and webinars

From Minimally Invasive Procedure to Photocoagulation: Personalized retinal care with Navilas® (Japanese)

  • Type:
  • Presented:February 8, 2024
Priv.-Doz. Dr. med. Yoko Miura

On-Demand Webinar: Navilas in der täglichen Praxis

  • Type:
  • Presented:February 1, 2017
Dr. Bernd Fassebender
  • The treatment strategy and selected parameters presented in content listed here are solely the responsibility of the treating ophthalmologist, who is required to be familiar with the most recent literature/guidelines or recommendations, as well as with the usage of the Navilas Laser System according to the current Operator’s Manual.